Meeting
2022 ASCO Quality Care Symposium
Out-of-pocket costs for oral anticancer drugs.
Authors
Nivedita Arora
University of Minnesota, Minneapolis, MN
Nivedita Arora, S. M. Qasim Hussaini, Ramy Sedhom, Anne Hudson Blaes, Stacie B Dusetzina, Arjun Gupta
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Cost, Value, and Policy,Health Care Access, Equity, and Disparities,Patient Experience
Sub Track
Cost and Cost-Effectiveness of Care
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 14)
DOI
10.1200/JCO.2022.40.28_suppl.014
Abstract #
14
Poster Bd #
A12
Abstract Disclosures
Funded by Conquer Cancer
Similar Posters
Poster
2021 ASCO Quality Care Symposium
Medicare Part D spending for the 10 costliest oral anticancer drugs.
First Author: Kaitlyn McBride
Poster
2019 ASCO Annual Meeting
Cost of oral cancer drugs: Trends in the United States Medicare population in 2013 and 2015.
First Author: Kira Rose-Madison Seiger
Poster
2023 ASCO Quality Care Symposium
Potential out-of-pocket savings from hematology/oncology drugs for commercially insured patients via Mark Cuban Cost Plus Drug Company.
First Author: Jenny Jing Xiang
Poster
2016 ASCO Annual Meeting
Rising financial burden of targeted oral anticancer medications on the Medicare Part D program and its beneficiaries.
First Author: Ya-Chen T. Shih